专利视角下人工智能辅助药物研发现状问题与我国创新策略研究  

Research on the Status Quo of AIDD Research and Development and China’s Innovation Strategy from the Perspective of Patent

作　　者：朱珈震 李静 张静 ZHU Jiazhen;LI Jing;ZHANG Jing(School of Science,China Pharmaceutical University,Nanjing 211198;Library and Information Center,China Pharmaceutical University,Nanjing 211198;Journal Editorial Department,China Pharmaceutical University,Nanjing 210009)

机构地区：[1]中国药科大学理学院,南京211198 [2]中国药科大学图书与信息中心,南京211198 [3]中国药科大学期刊编辑部,南京210009

出　　处：《中国发明与专利》2024年第10期71-79,共9页China Invention & Patent

摘　　要：近年来随着人工智能技术的不断发展和应用,药物研发也面临着新的机遇和挑战,人工智能在药物研发的应用已经成为研究热点,其中专利作为反映技术创新和发展的重要指标对药物相关人工智能技术的研究具有重要的意义,分析药学领域人工智能专利能够为产业发展提供借鉴与参考。对专利公开情况、国内发展情况以及技术特点等专利信息进行研究分析可以窥探人工智能辅助药物研发领域的现状与挑战。In recent years,with the continuous development and application of artificial intelligence technology,drug research and development are also facing new opportunities and challenges.The application of artificial intelligence in drug research and development has become a research hotspot,among which patents,as an important indicator reflecting technological innovation and development,are of great significance to the research of drug-related artificial intelligence technology.The analysis of artificial intelligence patents in pharmaceutical field can provide references for industrial development.The research and analysis of patent information such as patent disclosure,domestic development and technical characteristics can probe the status quo and challenges in the field of AI-assisted drug research and development.

关 键 词：人工智能 专利分析 药物研发 发明专利 创新策略 

分 类 号：G306[文化科学]